- Non-binding agreement between Oracle and AstraZeneca announced Oct 20, 2026.
Oracle and AstraZeneca signed a non-binding agreement to explore AI and real-world data applications in clinical trials and care workflows, targeting faster patient recruitment and continuous evidence generation across multiple disease areas.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.